MedPath

Cardiorespiratory Fitness in Prediabetic,Type 2 Diabetic and Healthy Individuals

Completed
Conditions
Diabetes Mellitus, Type 2
Prediabetic State
Cardiorespiratory Fitness
Inflammation
Exercise Test
Interventions
Diagnostic Test: Cardiorespiratory Fitness
Registration Number
NCT03823664
Lead Sponsor
Hacettepe University
Brief Summary

The aim of this study to investigate and compare cardiorespiratory fitness (CRF) parameters of prediabetic, type 2 diabetic and healthy individuals. CRF assessed with cardiopulmonary exercise test (CPET) which is gold standard measure of CRF. Pulmonary functions, inflammation, disease specific parameters such as HbA1c, fasting plasma glucose etc affect CRF in prediabetic and type 2 diabetics.All parameters examine in this study.

Detailed Description

This study will be participated with Type 2 diabetic,prediabetic and healthy patients. Patients' laboratory values, pulmonary function test, respiratory muscle strength, exercise capacity, physical activity level, quality of life, cardiorespiratory fitness levels will assess and record. Pulmonary function test will be assesed with CPET system, respiratory muscle strength will be evaluated with mouth pressure. Exercise capacity will be evaluated using six minute walking test, incremental shuttle walk test. And cardiorespiratory fitness will assess CPET system. Physical activity level will be evaluated trial accelerometer and International Physical Activity Questionnaire.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
48
Inclusion Criteria
  • Cooperation,
  • No assistance for Ambulation,
  • Body Mass Index<40
  • Diagnose of prediabetes/type 2 diabetes and health
Exclusion Criteria
  • Any cardiac problems,
  • Uncontrolled hypertension,
  • Any neurologic disease,
  • Uncontrolled diabetes,
  • Any orthopedic disease impairs walking, balance
  • Any respiratory disease affects cardiorespiratory fitness

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
Type 2 DiabeticCardiorespiratory FitnessFasting Plasma Glucose ≥126 mg/dL (7.0 mmol/L). OR \* A1C ≥6.5% (48 mmol/mol). OR \* Patients with classic symptoms of hyperglycemia or hyperglycemic crisis, a random plasma glucose ≥200 mg/dL (11.1 mmol/L).OR\* 2-h Plasma Glucose ≥200 mg/dL (11.1 mmol/L) during oral glucose tolerance test\* \* American Diabetes As. (ADA) type 2 diabetes diagnosis criteria
PrediabeticCardiorespiratory FitnessFasting Plasma Glucose 100 mg/dL (5.6 mmol/L) to 125 mg/dL (6.9 mmol/L) (Impaired Fasting Glucose)\* OR A1C 5.7-6.4% (39-47 mmol/mol)\* OR 2-h Plasma Glucose during 75-g Oral Glucose Tolerance Test 140 mg/dL (7.8 mmol/L) to 199 mg/dL (11.0 mmol/L) (Impaired Glucose Tolerance)\* \* ADA prediabetes criteria
HealthyCardiorespiratory FitnessHealthy glucose metabolism and according to endocrinology visit no health problems related or affect cardiorespiratory fitness and other parameters examined in this study.
Primary Outcome Measures
NameTimeMethod
Cardiorespiratory fitnessNovember 2018-August 2019

Refers to the ability of the circulatory and respiratory systems to supply oxygen to skeletal muscles during sustained physical exercise. It will be evaluated with Cardiopulmonary Exercise Test (CPET,CPX) System

Secondary Outcome Measures
NameTimeMethod
Respiratory Muscle StrengthDecember 2018-August 2019

Mouth pressures; maximal inspiratory and expiratory pressure

Maximal Exercise CapacityDecember 2018-August 2019

İncremental Shuttle Walk Test

Physical Activity LevelDecember 2018-August 2019

Accelerometer

Pulmonary functionsDecember 2018-August 2019

Peak expiratory flow (PEF)

Functional Exercise CapacityDecember 2018-August 2019

6 Minutes Walk Test's distance, meters

Trial Locations

Locations (1)

Hacettepe University

🇹🇷

Ankara, Turkey

© Copyright 2025. All Rights Reserved by MedPath